Versant Ventures
Carlo Rizzuto is a Managing Director and Partner at Versant Ventures. Carlo has a diverse background in the biotech industry, having held various leadership roles at companies such as Highline Therapeutics and Novartis. With a PhD in Virology from Harvard University, Carlo has a strong educational foundation that complements their extensive professional experience in business development and global program management.
This person is not in any offices
Versant Ventures
1 followers
Versant Ventures is a leading healthcare investment firm committed to helping exceptional entrepreneurs build the next generation of great companies. The firm’s emphasis is on biotechnology companies that are discovering and developing novel therapeutics. With $2.4 billion under management and offices in the U.S., Canada and Europe, Versant has built a team with deep investment, operating and clinical expertise that enables a hands-on approach to company building. Since the firm’s founding in 1999, more than 70 Versant companies have achieved successful acquisitions or IPOs.